Sphygmomanometers are the cornerstone of blood pressure management and yet there is no national standard for the regulation of this equipment in the UK. It is known that these machines may often be inaccurate, particularly those used in the community. We embarked upon a survey of all sphygmomanometers in current use in one inner city primary care group. Contrary to our initial hypothesis, inaccuracy rates were lower than
Introduction
The National Service Framework on the management of cardiovascular disease has just been published 1 and yet none of its 12 standards makes mention of the need to detect and manage hypertension using accurately calibrated sphygmomanometers. There is already a substantial literature documenting the inaccuracies of sphygmomanometers. [2] [3] [4] [5] [6] The reported proportion of inaccurate machines has varied according to the type and age of machine, the frequency of servicing, the setting of the study and the criteria used to define inaccuracy.
In a survey of both hospital and primary care based machines, Burke et al 2 examined 210 sphygmomanometers and found that 30% of anaeroid and 2% of mercury machines were inaccurate. All the anaeroid models were used in primary care. Inaccuracy in this study was defined as errors greater than ±4 mm Hg. Anaeroid machines were the subject of a more detailed, hospital based study 3 in which 35% of a sample of 230 were found to be inaccurate (greater than ±3 mm Hg), mostly at the upper pressure ranges of 150 mm Hg or greater. The majority (86%) of intolerant manometers read lower than a standardised manometer. Higher proportions of inaccurate manometers were found in a Brazilian survey 4 machines used in private practice were inaccurate (greater than ± 3 mm Hg). Greater inaccuracy in anaeroid machines than mercury machines is attributable to the delicacy of their spring balance mechanism which can easily become damaged if subjected to jolts and recalibration is recommended every 6 months. 5, 6 In spite of this, a large survey of GPs in Yorkshire and Humberside revealed that 23.5% of 1223 GPs had never had their sphygmomanometer serviced. 7 With the formation of Primary Care Groups (PCGs) in 1999, an opportunity arose to study the accuracy of all sphygmomanometers used to measure blood pressure in one particular community. Unlike previous studies investigating selected volunteer practices, we were able to conduct a survey of each practice within one PCG. We hypothesised that an inclusive survey would reveal even higher inaccuracy rates. Knowing that our PCG contained a wide range of primary care, we also hypothesised that inaccuracy would cluster in the less well developed practices and that newer, more frequently calibrated and more accurate machines would be a feature of better developed practices.
To test these hypotheses, we embarked upon a survey of all sphygmomanometers in use in primary care in one inner city PCG and gathered practice data in order to identify the type of practice more likely to harbour inaccurate machines.
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Materials and methods
Setting
North Lambeth PCG is located in a deprived area of south London. It consists of 32 general practices, and 96 GPs. The practices varied considerably in their development with some supporting an extended primary care team in modern premises whilst others were in poor premises and one did not have practice nurses.
Survey technique
All practices in the PCG were invited to participate in a baseline assessment of sphygmomanometer accuracy which was part of the cardiovascular disease prevention programme being implemented by the PCG. Practices were asked to collect every single one of their anaeroid and mercury sphygmomanometers in everyday use; digital sphygmomanometers were excluded because of the specialist machinery needed for accurate calibration. One of us (AD) was commissioned by the PCG to visit each practice to conduct the calibration according to a protocol (see below).
To ensure that all machines were presented for testing at the time of the practice visit, an independent postal survey was conducted by the PCG prior to the visit. Information was sought on the type, number, age and service histories of sphygmomanometers at the practice together with details of the hypertension protocols currently in use in the PCG. This exercise was linked with an offer of training in the techniques of blood pressure measurement. Details of the postal survey were available at the time of the visit and the numbers reported were used to retrieve any missing machines, not presented for calibration.
Calibration
A new mercury sphygmomanometer provided by AstraZeneca was used as the standard against which all other machines were compared. Using a Y-converter tube, readings on the test machines could be compared with the standardised sphygmomanometer reading. To conduct the test, each machine was inflated to a reading of 220 mm Hg on the standardised sphygmomanometer. The reading on the machine being tested was noted. Four more readings were taken on each machine at pressures of 200 mm Hg, 150 mm Hg, 100 mm Hg and 50 mm Hg.
In line with current recommendations, 5, 6 machines producing an error of 4 mm Hg or more at any one of the five test pressures were deemed to be inaccurate. Based on the recommendation that servicing should occur every 6 months, the date of the last service was recorded together with the date of purchase. The general condition of each of each machine was recorded.
Practice data
Routine data was collected from each of the practices in the PCG covering practice characteristics and two performance measures: achievement of cervical smear targets and vaccination targets.
Statistical analysis
Data were analysed using the statistical package, SPSS for Windows. When exploring the relationship between categorical variables describing the practice and whether a machine 'passed' or 'failed', the 2 test with Yates correction was employed and the P value interpreted using Fisher's exact two-tailed test. When exploring continuous variables with the results of sphygmomanometer calibration, MannWhitney's test for non-parametric data was used.
Results
Numbers of sphygmomanometers
All 32 practices in the PCG agreed to participate. A total of 191 machines were tested (130 mercury and 61 anaeroid) in the 32 practices. A further 17 digital machines were identified but these were excluded from the survey.
Inaccurate sphygmomanometers
A total of 12 (6.3%) sphygmomanometers were found to be inaccurate: three (2.3%) mercury, nine (14.8%) anaeroid. The greater proportion of anaeroid sphygmomanometers 'failing' calibration testing when compared to mercury sphygmomanometers was highly significant: 2 = 7.37, P = 0.004. The greater likelihood of inaccuracy in an anaeroid as opposed to a mercury machine can be expressed as an odds ratio: 6.35 (95% confidence intervals: 1.50 to 30.81).
Age and service history
Detailed analysis of sphygmomanometer age could not be conducted because of the lack of written confirmation of service and purchase dates. Most machines which 'failed' appeared to have been infrequently serviced and elderly with several of the anaeroids said to be over 10 years old, one being 25 years old. One anaeroid 'failed' even though it was less than 1 year since purchase. In assessing the general condition of machines none were deemed to have 'failed' because of defective tubing, inflation bulb valves nor poorly cleaned glass manometers.
Relationship to practice characteristics
A summary of practice characteristics linked to the condition of their sphygmomanometers is given in Table 1 . The 12 machines that failed calibration testing were located in 11 practices. Somewhat higher proportions of 'failures' occurred in some types of practices, but the differences did not reach statistical significance:
• group practices-nine out of 20 (45%) group practices had an inaccurate sphygmomanometer, vs two out of 12 (17%) singlehanders • practices achieving the higher vaccine targetseven out of 15 (47%) achieving the higher target practices had an inaccurate sphygmomanometer, vs four out of 17 (24%) not achieving the target.
When the proportions of anaeroid to mercury manometers were compared, there were no significant differences between practices achieving and those not achieving their targets for smears and vaccines. When compared with the number of partners in the practice, those practices with poorly calibrated machines were significantly more likely to have larger numbers of GP principals: mean number of GPs was 4.0 vs 2.3 in those with well calibrated machines (Mann-Whitney U = 59.5; P = 0.02).
Although there was a tendency for practices with poorly calibrated machines to have smaller list sizes a To achieve the higher vaccine target, 90% of all registered 2 year olds in the practice should be up-to-date with their vaccines; to achieve the lower target, the figure is 70%.
b To achieve the higher cervical smear target, 80% of registered women aged 25-65 years should have had a smear in the preceding 5 years; to achieve the lower target, the figure is 50%.
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per GP (2046 vs 2615), the difference was not significant (Mann-Whitney U = 82.0; P = 0.18).
Conclusions
A total of 6% of the sphygmomanometers in use in the PCG were found to be inaccurate with anaeroid sphygmomanometers being over six times more likely to be give a false reading. Unlike previous surveys of selected volunteer practices, we were able to determine the accuracy of all the machines used to monitor blood pressure for this particular community in south London. It is possible that some machines were not included in our survey although reconciling data from the postal survey and from the calibration exercise led us to believe that few, if any, sphygmomanometers in regular use had been missed. Contrary to what might be thought, faulty sphygmomanometers were found in all types of practices and not just the less well developed. Indeed, they were somewhat more likely to be faulty in training practices and those achieving higher vaccine targets. Faulty sphygmomanometers were significantly more likely to be found in larger group practices. The bleak picture of uncalibrated sphygmomanometers clustering in the practices of isolated singlehanders who fail to reach smear and vaccine targets is not supported by the evidence.
If an exercise to calibrate machines is to be undertaken regularly, then all practices and all machines need to be included. A possible reason for otherwise 'successful' practices having inaccurate sphygmomanometers is that many of these actively refused access to any pharmaceutical representative, many of whom were offering a manometer calibration service and yet the practices had not made alternative arrangements for a service. A higher ratio of anaeroid to mercury sphygmomanometers did not account for the poor results observed in these 'successful' practices. Possibly such practices are incentivised more by a performance indicator that is being monitored, rather than by one that has not traditionally been seen as defining a good practice.
If PCGs are to plan for successful treatment of hypertension on their 'patch', then calibration of all sphygmomanometers in use in primary care is essential, given the inaccuracies demonstrated by this survey. All practices need to be aware of their responsibilities to keep equipment well maintained in order to ensure accuracy and this survey suggests that this responsibility may be neglected just as much, if not more, in better developed practices. At present, regular calibration checks are merely advised, but the European Union is expected to introduce regulations making annual checks a requirement. 8 Until the arrival of such regulations, the current situation is such that not one out of 237 practices recently surveyed in the Birmingham area had an arrangement for servicing and recalibrating sphygmomanometers. 9 The usual direction of inac-
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curacy in anaeroid sphygmomanometers is underreading, 10 and as a result, poor calibration within a PCG translates into under-detection and under-treatment of hypertension within that community.
Having found inaccurate sphygmomanometers, we have no information about the willingness of practices to recalibrate or purchase new equipment. Our own PCG has responded by incorporating this requirement into clinical governance. Until the implementation of a more compulsory framework for sphygmomanometer calibration, adoption of regular calibration as a performance indicator in primary care might be one means of achieving far greater accuracy of blood pressure management.
